Bio-Path Holdings, Inc. short interest in 2022
In 2022, Bio-Path Holdings, Inc.'s disclosed short interest ran from 1.72% of shares outstanding on 14 Jan 2022 to 0.36% on 30 Dec 2022, a change of -1.36 percentage points. The year's high was 1.85% on 31 Jan 2022 and its low 0.36% on 30 Dec 2022, averaging 0.94% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.53 days on 15 Feb 2022. Full history: Bio-Path Holdings, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2022 in figures
- Start of year
- 1.72% (14 Jan 2022)
- End of year
- 0.36% (30 Dec 2022)
- Change
- -1.36 pp
- High
- 1.85% (31 Jan 2022)
- Low
- 0.36% (30 Dec 2022)
- Average
- 0.94%
- Highest days to cover
- 3.53 (15 Feb 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 1.72% | 2.66 | |
| 31 Jan 2022 | 1.85% | 2.54 | |
| 15 Feb 2022 | 1.54% | 3.53 | |
| 28 Feb 2022 | 1.54% | 3.23 | |
| 15 Mar 2022 | 1.23% | 2.81 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 0.84% | 1.91 | |
| 14 Apr 2022 | 1.34% | 1.00 | |
| 29 Apr 2022 | 0.94% | 1.32 | |
| 13 May 2022 | 1.40% | 1.88 | |
| 31 May 2022 | 1.15% | 2.56 | 10-Q filed, results (8-K) |
| 15 Jun 2022 | 1.24% | 3.02 | |
| 30 Jun 2022 | 0.86% | 1.00 | |
| 15 Jul 2022 | 0.74% | 2.17 | |
| 29 Jul 2022 | 0.73% | 1.91 | |
| 15 Aug 2022 | 0.67% | 1.55 | 10-Q filed |
| 31 Aug 2022 | 0.60% | 3.03 | results (8-K) |
| 15 Sep 2022 | 0.52% | 3.13 | |
| 30 Sep 2022 | 0.48% | 1.39 | |
| 14 Oct 2022 | 0.48% | 3.24 | |
| 31 Oct 2022 | 0.48% | 2.94 | |
| 15 Nov 2022 | 0.41% | 1.00 | 10-Q filed, results (8-K) |
| 15 Dec 2022 | 0.46% | 1.00 | |
| 30 Dec 2022 | 0.36% | 1.00 |
See also: Bio-Path Holdings, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.